NIH Offers $129.3 Million to Boost National Covid-19 Testing Capacity
NIH is awarding contracts to nine companies in support of new covid-19 testing technologies as part of its Rapid Acceleration of Diagnostics initiative.
Read MorePosted by Laurie Bonner | Sep 3, 2020 | Lab Management |
NIH is awarding contracts to nine companies in support of new covid-19 testing technologies as part of its Rapid Acceleration of Diagnostics initiative.
Read MorePosted by Melanie Hamilton-Basich | Sep 2, 2020 | Covid 19, Rapid Assays |
Roche will launch a covid-19 Rapid Antigen Test in late September for markets accepting the CE Mark.
Read MorePosted by Laurie Bonner | Sep 2, 2020 | Hematology & Serology |
DNA origami—a nanoscale technique that involves folding DNA into specific shapes—can compile a detectable signal from just a few biomarkers.
Read MorePosted by Melanie Hamilton-Basich | Sep 1, 2020 | Covid 19, Point-of-Care |
Access Anti-SARS-CoV-2 is an easy-to-use 10-minute test on a portable device that provides highly accurate results on Total Ig antibodies.
Read MorePosted by Melanie Hamilton-Basich | Sep 1, 2020 | Company News, Covid 19, Hematology & Serology |
The rapid-results test requires only a fingerstick and delivers results in 15 minutes.
Read More